Search

everythinglearnresearchcommunity

for

Search:↓

Some patients developed hair loss after islet cell transplant possibly due to their immune-suppressing medications.

Rejuvenating self-repair mechanisms could improve organ recovery in regenerative medicine.

Corticosteroids are the most effective treatment for Satoyoshi syndrome.

A 70-year-old woman with bronchiectasis developed a rare immune disease due to a bacterial infection, requiring a difficult balance of treatments.

The conclusion is that effective cancer treatment often requires a combination of therapies, but must be carefully managed due to serious side effects and the risk of immunosuppression.

Timely diagnosis and aggressive treatment with high-dose steroids and B-cell depletion therapies are effective for severe acute cutaneous lupus.

Skin disorders in HIV patients have shifted, with more sexually transmitted infections and ART-related conditions now common.

Transplant patients face higher skin cancer risks due to immunosuppressive therapy, requiring careful skin health monitoring.

Person-to-person hair transplants can work for patients on lifelong immunosuppression, with high hair growth success.

Transplant patients often get skin problems, with treatments varying by condition.

A heart transplant patient developed a skin condition called epidermodysplasia verruciformis after taking immune-suppressing drugs.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

A disease causing skin issues in young adult German short-haired pointers is hereditary, with most affected dogs not responding to treatment.

Some anticonvulsant drugs can cause skin reactions, ranging from mild to severe, and managing these reactions is important for patient care.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

A boy with a rare skin condition and kidney disease improved with cyclosporine after steroids failed, suggesting a new treatment approach.

Rituximab may be an effective treatment for Cronkhite-Canada syndrome with kidney disease.

There is no gold standard treatment for hidradenitis suppurativa due to insufficient evidence.

The document suggests that severe hair loss in SLE patients may be an early sign of scalp DLE, treatable with immunosuppressive therapy.

Trichoscopy can reveal specific hair and scalp changes in linear morphea.

Discoid lupus erythematosus can be mistaken for a skin infection, complicating diagnosis and treatment.

Uveodermatological syndrome in dogs is hard to manage and can lead to blindness despite treatment.

Early recognition and a multidisciplinary approach are crucial for effectively managing complex autoimmune conditions like SLE with CAPS and AHA.

Type B Insulin Resistance Syndrome is rare, linked to lupus, and hard to treat due to severe insulin resistance.

TB lymphadenitis can occur in people with SLE on long-term immunosuppressive therapy.

Early referral to a pediatric rheumatologist and thorough evaluation are crucial for treating complex overlap syndromes effectively.

A young woman with lupus developed tuberculosis due to weakened immunity from her medication, showing the need for better TB screening in such patients.

Early diagnosis and aggressive treatment are crucial for managing SLE-related pancreatitis in children.

A patient with both bullous lichen planus and systemic lupus erythematosus showed improvement with treatment.

A patient with "strawberry gingivitis" improved after correct treatment for Granulomatosis with polyangiitis, highlighting the need for early diagnosis.